Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1918 1
1919 1
1931 1
1947 1
1962 1
1968 1
1994 2
1996 2
1997 2
1999 2
2001 1
2002 1
2003 4
2004 3
2005 1
2006 2
2007 4
2008 7
2009 7
2010 11
2011 3
2012 12
2013 13
2014 9
2015 13
2016 9
2017 13
2018 17
2019 20
2020 29
2021 25
2022 17
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Sleep and Athletic Performance.
Watson AM. Watson AM. Curr Sports Med Rep. 2017 Nov/Dec;16(6):413-418. doi: 10.1249/JSR.0000000000000418. Curr Sports Med Rep. 2017. PMID: 29135639 Review.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Wang ES, Montesinos P, Minden MD, Lee JH, Heuser M, Naoe T, Chou WC, Laribi K, Esteve J, Altman JK, Havelange V, Watson AM, Gambacorti-Passerini C, Patkowska E, Liu S, Wu R, Philipose N, Hill JE, Gill SC, Rich ES, Tiu RV. Wang ES, et al. Among authors: watson am. Blood. 2022 Oct 27;140(17):1845-1857. doi: 10.1182/blood.2021014586. Blood. 2022. PMID: 35917453 Free PMC article. Clinical Trial.
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Zeidan AM, Borate U, Pollyea DA, Brunner AM, Roncolato F, Garcia JS, Filshie R, Odenike O, Watson AM, Krishnadasan R, Bajel A, Naqvi K, Zha J, Cheng WH, Zhou Y, Hoffman D, Harb JG, Potluri J, Garcia-Manero G. Zeidan AM, et al. Among authors: watson am. Am J Hematol. 2023 Feb;98(2):272-281. doi: 10.1002/ajh.26771. Epub 2022 Nov 10. Am J Hematol. 2023. PMID: 36309981 Free PMC article. Clinical Trial.
Authors' Response.
Bell DR, Nelson EO, Watson AM, Kliethermes SA, Snedden TR, McGuine TA. Bell DR, et al. Among authors: watson am. J Athl Train. 2021 Nov 1;56(11):1255-1257. doi: 10.4085/1062-6050-1011-21. J Athl Train. 2021. PMID: 34752628 Free PMC article. No abstract available.
The Bomb.
Watson AM. Watson AM. J Clin Oncol. 2019 Apr 1;37(10):850-851. doi: 10.1200/JCO.18.02087. Epub 2019 Feb 11. J Clin Oncol. 2019. PMID: 30742564 No abstract available.
Mental Health and Well-Being in Athletes.
Watson AM. Watson AM. Sports Health. 2024 Mar-Apr;16(2):164-165. doi: 10.1177/19417381241230451. Sports Health. 2024. PMID: 38441105 No abstract available.
Frataxin deficiency promotes endothelial senescence in pulmonary hypertension.
Culley MK, Zhao J, Tai YY, Tang Y, Perk D, Negi V, Yu Q, Woodcock CC, Handen A, Speyer G, Kim S, Lai YC, Satoh T, Watson AM, Aaraj YA, Sembrat J, Rojas M, Goncharov D, Goncharova EA, Khan OF, Anderson DG, Dahlman JE, Gurkar AU, Lafyatis R, Fayyaz AU, Redfield MM, Gladwin MT, Rabinovitch M, Gu M, Bertero T, Chan SY. Culley MK, et al. Among authors: watson am. J Clin Invest. 2021 Jun 1;131(11):e136459. doi: 10.1172/JCI136459. J Clin Invest. 2021. PMID: 33905372 Free PMC article.
Pathology in Practice.
Watson AM, Jenkins TL, Rissi DR. Watson AM, et al. J Am Vet Med Assoc. 2017 Dec 1;251(11):1253-1255. doi: 10.2460/javma.251.11.1253. J Am Vet Med Assoc. 2017. PMID: 29154710 Free article. No abstract available.
Vascular Aging and Vascular Disease Have Much in Common!
Watson AMD, Chen YC, Peter K. Watson AMD, et al. Arterioscler Thromb Vasc Biol. 2022 Aug;42(8):1077-1080. doi: 10.1161/ATVBAHA.122.317892. Epub 2022 Jun 23. Arterioscler Thromb Vasc Biol. 2022. PMID: 35735019 Free article. No abstract available.
Sexually dimorphic mechanisms of VGLUT-mediated protection from dopaminergic neurodegeneration.
Buck SA, Rubin SA, Kunkhyen T, Treiber CD, Xue X, Fenno LE, Mabry SJ, Sundar VR, Yang Z, Shah D, Ketchesin KD, Becker-Krail DD, Vasylieva I, Smith MC, Weisel FJ, Wang W, Erickson-Oberg MQ, O'Leary EI, Aravind E, Ramakrishnan C, Kim YS, Wu Y, Quick M, Coleman JA, MacDonald WA, Elbakri R, De Miranda BR, Palladino MJ, McCabe BD, Fish KN, Seney ML, Rayport S, Mingote S, Deisseroth K, Hnasko TS, Awatramani R, Watson AM, Waddell S, Cheetham CEJ, Logan RW, Freyberg Z. Buck SA, et al. Among authors: watson am. bioRxiv [Preprint]. 2023 Oct 3:2023.10.02.560584. doi: 10.1101/2023.10.02.560584. bioRxiv. 2023. PMID: 37873436 Free PMC article. Preprint.
234 results